G. Christodoulakos

发表

The effect of various regimens of hormone replacement therapy on mammographic breast density.

I. Lambrinoudaki, E. Georgiou, G. Creatsas, 2003, Maturitas.

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study

I. Lambrinoudaki, D. Kelekis, G. Creatsas, 2002, Menopause.

Menopause and Atherosclerosis Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors

I. Lambrinoudaki, M. Alevizaki, P. Sfikakis, 2013 .

Continuous combined replacement therapy in postmenopausal women: effect on plasma lipoproteins, bone mass and the endometrium.

G. Creatsas, C. Siristatidis, G. Christodoulakos, 2002, Hormones.

Pathogenesis of endometriosis: The role of defective ‘immunosurveillance’

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The differential effect of estrogen, estrogen–progestin and tibolone on coagulation inhibitors in postmenopausal women

I. Lambrinoudaki, J. Bramis, A. Alexandrou, 2007, Climacteric : the journal of the International Menopause Society.

Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.

I. Lambrinoudaki, G. Creatsas, A. Alexandrou, 2008, Maturitas.

Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women

I. Lambrinoudaki, M. Creatsa, G. Christodoulakos, 2008, Climacteric : the journal of the International Menopause Society.

Differential Effect of Hormone Therapy and Tibolone on Lipids, Lipoproteins, and the Atherogenic Index of Plasma

I. Lambrinoudaki, G. Creatsas, G. Christodoulakos, 2006, Journal of cardiovascular pharmacology.

Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.

I. Lambrinoudaki, A. Alexandrou, A. Sarandakou, 2004, European journal of endocrinology.

Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women.

I. Lambrinoudaki, G. Creatsas, A. Alexandrou, 2006, Hormones.

Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women

I. Lambrinoudaki, G. Creatsas, D. Rizos, 2005, Journal of Bone and Mineral Metabolism.

Cardiovascular disease: screening and management of the a-symptomatic high-risk post-menopausal woman.

I. Lambrinoudaki, G. Christodoulakos, G. Creatsas, 2005, Maturitas.

The role of the oxidative-stress in the endometriosis-related infertility

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women

I. Lambrinoudaki, G. Christodoulakos, C. Panoulis, 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2006, Maturitas.

Bisphosphonates

I. Lambrinoudaki, G. Christodoulakos, D. Botsis, 2006, Annals of the New York Academy of Sciences.

The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.

G. Creatsas, G. Christodoulakos, D. Botsis, 2006, Maturitas.

Serum lipids and apolipoproteins in Greek postmenopausal women: Association with estrogen, estrogen-progestin, tibolone and raloxifene therapy

I. Lambrinoudaki, G. Christodoulakos, C. Panoulis, 2003, Journal of endocrinological investigation.

The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: A pilot study

I. Lambrinoudaki, G. Kaparos, P. Pliatsika, 2011, The journal of obstetrics and gynaecology research.

Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women.

I. Lambrinoudaki, G. Kaparos, A. Alexandrou, 2008, European journal of endocrinology.

Methylenetetrahydrofolate reductase C 677 T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women

I. Lambrinoudaki, G. Kaparos, A. Alexandrou, 2008 .

Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2004, Maturitas.

Determinants of serum leptin levels in healthy postmenopausal women

I. Lambrinoudaki, A. Augoulea, G. Christodoulakos, 2003, Journal of endocrinological investigation.

The frequency of early, spontaneous miscarriage associated with the leu33pro polymorphism of Glycoprotein IIIa: A pilot study

I. Lambrinoudaki, A. Alexandrou, M. Creatsa, 2010, The Australian & New Zealand journal of obstetrics & gynaecology.

Apolipoprotein E and Paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women

I. Lambrinoudaki, G. Kaparos, A. Alexandrou, 2009, Clinical endocrinology.

Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women.

I. Lambrinoudaki, G. Creatsas, D. Rizos, 2003, Fertility and sterility.

Doppler Assessment of the Intrauterine Growth‐Restricted Fetus

G. Christodoulakos, D. Botsis, N. Vrachnis, 2006, Annals of the New York Academy of Sciences.

The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women

I. Lambrinoudaki, G. Kaparos, A. Alexandrou, 2010, Journal of endocrinological investigation.

Ovarian endometriosis associated with ovarian cancer and endometrial–endocervical polyps

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2007, The journal of obstetrics and gynaecology research.

Measurable serum markers of oxidative stress response in women with endometriosis.

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2009, Fertility and sterility.

The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women

I. Lambrinoudaki, G. Creatsas, G. Christodoulakos, 2004, Menopause.

Homocysteine and folate levels in postmenopausal women.

G. Christodoulakos, C. Panoulis, I. Phocas, 2001, Maturitas.

Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

I. Lambrinoudaki, G. Christodoulakos, C. Panoulis, 2005, Maturitas.

Association between serum tumor necrosis factor‐α and corticotropin‐releasing hormone levels in women with preterm labor

G. Creatsas, N. Vitoratos, G. Christodoulakos, 2006, The journal of obstetrics and gynaecology research.

Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.

I. Lambrinoudaki, G. Lyritis, G. Creatsas, 2005, Contraception.

Effects of estrogen–progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis

G. Christodoulakos, C. Panoulis, S. Dendrinos, 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Thyroid autoimmunity in patients with recurrent spontaneous miscarriages

G. Creatsas, G. Christodoulakos, S. Dendrinos, 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.

I. Lambrinoudaki, N. Vitoratos, G. Creatsas, 2007, Atherosclerosis.

The Cardiovascular Effects of Selective Estrogen Receptor Modulators

I. Lambrinoudaki, G. Christodoulakos, D. Botsis, 2006, Annals of the New York Academy of Sciences.

Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women.

I. Lambrinoudaki, G. Creatsas, G. Christodoulakos, 2004, Fertility and sterility.

Thoracic Endometriosis Syndrome

I. Lambrinoudaki, A. Augoulea, G. Christodoulakos, 2007, Respiration.

Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women.

I. Lambrinoudaki, G. Creatsas, D. Rizos, 2004, European journal of obstetrics, gynecology, and reproductive biology.

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women*

D. Mellström, T. Nickelsen, I. Pávó, 2007, Current medical research and opinion.

Irritability in Menopause: An Investigation of Its Relation to Menopausal, Hormonal and Physical Factors

I. Lambrinoudaki, D. Rizos, G. Christodoulakos, 2009, Psychotherapy and Psychosomatics.

Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors

Petros P. Sfikakis, Kimon Stamatelopoulos, Dimitrios Rizos, 2009, Hypertension.

Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women

I. Lambrinoudaki, G. Christodoulakos, N. Tentolouris, 2005, Journal of endocrinological investigation.

Quality of life and psychological symptoms in Greek postmenopausal women: Association with hormone therapy

I. Lambrinoudaki, G. Creatsas, G. Christodoulakos, 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels

I. Lambrinoudaki, G. Creatsas, A. Augoulea, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.

I. Lambrinoudaki, M. Creatsa, D. Rizos, 2006, European journal of endocrinology.

CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women

I. Lambrinoudaki, C. Papamichael, K. Stamatelopoulos, 2008, Menopause.

[Pregnancy following pelvic spleen exstirpation with urogenital abnormalities].

G. Christodoulakos, D. Botsis, D. Kalogirou, 1979, Archives of Gynecology.

Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.

I. Lambrinoudaki, M. Creatsa, D. Rizos, 2010, Fertility and sterility.

Apoptosis in atherosclerosis: a mini-review.

I. Lambrinoudaki, G. Christodoulakos, M. Karaflou, 2008, Mini reviews in medicinal chemistry.

Breast pain and mammographic density increase as a consequence of raloxifene therapy

I. Lambrinoudaki, G. Christodoulakos, K. Panoulis, 2002, Journal of endocrinological investigation.

Progestin may modify the effect of low-dose hormone therapy on mammographic breast density

I. Lambrinoudaki, A. Augoulea, G. Christodoulakos, 2009, Climacteric : the journal of the International Menopause Society.

The effect of low dose hormone therapy on mammographic breast density

I. Lambrinoudaki, M. Creatsa, G. Christodoulakos, 2006 .

E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.

I. Lambrinoudaki, G. Creatsas, E. Politi, 2008, Fertility and sterility.

Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors

I. Lambrinoudaki, M. Alevizaki, P. Sfikakis, 2009, Hypertension.